Ecolab (ECL) Q4 2024 earnings summary

Executive summary

• Achieved record 2024 performance with strong organic sales growth, margin expansion, and robust free cash flow, driven by operational execution and investments in innovation, digital, and high-tech capabilities.

• U.S. remained the largest and most profitable region, leading growth, while international margins improved and new business wins contributed globally.

• Strategic focus on market share gains through the One Ecolab initiative and growth in high-tech, life sciences, and digital businesses.

• Reported diluted EPS for Q4 2024 was $1.66 (+18%), adjusted diluted EPS $1.81 (+17%), and full-year adjusted EPS reached $6.65.

• Confident 2025 outlook with double-digit adjusted EPS growth expected despite FX headwinds.

Financial highlights

• Q4 2024 organic sales grew 4% to $4,021.5M, with reported sales at $4,005.2M (+2%).

• Organic operating income margin for 2024 reached 16.8%–17.4%, up 140–150 bps year-over-year.

• Adjusted diluted EPS expected to grow 12%–15% in 2025, despite a 4% FX headwind.

• Free cash flow reached a record $1.8 billion in 2024, supporting increased dividends and share buybacks.

• Cash from operations for 2024 was $2.8 billion, up from $2.41 billion in 2023.

Outlook and guidance

• 2025 adjusted diluted EPS expected in the $7.42–$7.62 range (+12% to 15%), including a 4% currency headwind.

• Q1 2025 adjusted diluted EPS expected at $1.47–$1.53 (+10% to 14%), also including a 4% currency headwind.

• Targeting 20% operating income margin by 2027, with confidence in crossing 18% in 2025.

• 2025 organic sales growth expected to slightly exceed 2024’s 4%, with 2% volume growth and 2%–3% value pricing.

• CapEx to sales ratio projected at 7% in 2025, reflecting investments in digital and high-tech growth engines.